- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 453/00 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
Patent holdings for IPC class C07D 453/00
Total number of patents in this class: 55
10-year publication summary
|
9
|
4
|
4
|
6
|
4
|
2
|
2
|
1
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Genzyme Corporation | 1219 |
8 |
| Chiesi Farmaceutici S.p.A. | 966 |
5 |
| Gilead Sciences, Inc. | 1979 |
3 |
| Bristol-myers Squibb Company | 4875 |
2 |
| Abbvie Inc. | 1789 |
2 |
| ArQule, Inc. | 138 |
2 |
| BRANDEIS University | 331 |
2 |
| Aprea Therapeutics AB | 14 |
2 |
| Glaxo Group Limited | 4228 |
1 |
| The Board of Trustees of the University of Illinois | 2680 |
1 |
| Vertex Pharmaceuticals Incorporated | 1584 |
1 |
| Alpharmagen LLC | 5 |
1 |
| Astellas Pharma Inc. | 1112 |
1 |
| Daiichi Sankyo Company, Limited | 1876 |
1 |
| Demerx, Inc. | 74 |
1 |
| Enanta Pharmaceuticals, Inc. | 428 |
1 |
| L'Universite Catholique de Louvain | 3 |
1 |
| Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V. | 1762 |
1 |
| Memory Pharmaceuticals Corporation | 29 |
1 |
| Merck Canada Inc. | 89 |
1 |
| Other owners | 17 |